FDA Drug Application (202385) for FELBAMATE by AMNEAL PHARMS

Back to FDA Applications sponsored by AMNEAL PHARMS

Application Number202385
Product Number001
FormSUSPENSION;ORAL
Dosage600MG/5ML
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AB Products meeting necessary bioequivalence requirements
Reference Drug
Drug NameFELBAMATE
Active IngredientFELBAMATE

Active IngredientCount
List of drugs with Active Ingredient FELBAMATE2


Back to FDA Applications sponsored by AMNEAL PHARMS